Personalis, Inc. cash flow statement
In fiscal 2025, Personalis, Inc.'s operations generated −$74.9m of cash; it spent $4.5m on capital projects, leaving free cash flow of −$79.5m.
Cash flow statement
| Fiscal year | 2017Dec 2017 | 2018Dec 2018 | 2019Dec 2019 | 2020Dec 2020 | 2021Dec 2021 | 2022Dec 2022 | 2023Dec 2023 | 2024Dec 2024 | 2025Dec 2025 | LTMJun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | 0 | 6 | −18 | −43 | −71 | −70 | −56 | −45 | −75 | −92 |
| Depreciation and amortisation | 1 | 3 | 5 | 6 | 6 | 8 | 11 | 11 | 10 | 10 |
| Stock-based pay | 1 | 1 | 5 | 8 | 14 | 19 | 14 | 11 | 9 | 11 |
| Capital spending | 5 | 8 | 8 | 3 | 11 | 50 | 11 | 2 | 5 | 9 |
| Free cash flow | −5 | −2 | −26 | −46 | −82 | −120 | −67 | −47 | −79 | −101 |
| Free cash flow after stock pay | −6 | −4 | −31 | −54 | −96 | −140 | −81 | −57 | −89 | −112 |
| Shares issued | — | — | 144 | 118 | 162 | — | 4 | 30 | 127 | 135 |
| Quarter | 2024 Q3Sept 2024 | 2024 Q4Dec 2024 | 2025 Q1Mar 2025 | 2025 Q2Jun 2025 | 2025 Q3Sept 2025 | 2025 Q4Dec 2025 | 2026 Q1Mar 2026 | 2026 Q2Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Cash from operations | −6 | −8 | −18 | −13 | −22 | −22 | −22 | −26 |
| Depreciation and amortisation | 3 | 3 | 3 | 3 | 2 | 2 | 2 | 2 |
| Stock-based pay | 3 | 3 | 2 | 3 | 2 | 2 | 3 | 4 |
| Capital spending | 0 | 1 | 3 | 0 | 2 | 0 | 3 | 4 |
| Free cash flow | −6 | −9 | −20 | −13 | −23 | −22 | −26 | −30 |
| Free cash flow after stock pay | −9 | −12 | −23 | −16 | −26 | −25 | −28 | −34 |
| Shares issued | 27 | 0 | 18 | 0 | 0 | 109 | 21 | 5 |
Compare with peers
- Exagen Inc. cash flow
- Burning Rock Biotech Ltd cash flow
- Codexis, Inc. cash flow
- 908 Devices Inc. cash flow
- Precipio, Inc. cash flow
Head to head: PSNL vs XGNBNR vs PSNLCDXS vs PSNLMASS vs PSNL
More: Life Sciences Tools & Services stocks compared, Health Care sector, rankings of US companies